Scholarlink

Background <p>Periinterventional imaging of patients with hepatocellular carcinoma (HCC) during local and locoregional therapies plays a crucial role in clinical outcome by guiding treatment allocation, planning, and application. However, there is a considerable variety in clinical routine in terms of timing, modality, and imaging protocols. This study aimed to guide the standardization of the imaging procedures for patients with HCC by conducting a Delphi consensus-finding survey.</p> Methods <p>A multidisciplinary, multinational survey was conducted to standardize the imaging of patients with HCC using the Delphi method.</p> Results <p>Under the guidance of the European Organisation for Research and Treatment of Cancer (EORTC) Imaging and Gastrointestinal Tract Cancer Groups and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the recommendations for imaging before, during, and after thermal ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy were established.</p> Conclusion <p>This consensus protocol provides a foundational guide for imaging in the daily clinical management of HCC patients, as well as for prospective studies assessing local and locoregional therapies.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>There are clear recommendations for the respective therapies/disease stages in HCC, but only to a limited extent for all-around imaging of local therapies</i>.</p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>This study conveyed a Delphi consensus-finding survey amongst European experts from multiple medical fields to standardize the periinterventional imaging of HCC patients</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>These recommendations can guide both daily clinical practice and prospective trials focused on local and locoregional therapies</i>.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月23日

查看全文
  • Osman Öcal,
  • Christoph Johannes Zech,
  • Maria Antonietta Bali,
  • David Pasquier,
  • Felix Mottaghy,
  • Ingo Einspieler,
  • Nikolaos Kartalis,
  • Irene Bargellini,
  • Roberto Iezzi,
  • Timm Denecke,
  • Wolfgang Gerhard Kunz,
  • Bernhard Gebauer,
  • Henning Wege,
  • Roberto Cannella,
  • Daniela Elena Oprea-Lager,
  • Arndt Vogel,
  • Bruno Sangro,
  • Max Seidensticker,
  • Francesca De Felice,
  • Serena Pisoni,
  • Hossein Hemmatazad,
  • Kerstin Schütte,
  • Joost Verhoeff,
  • Bora Peynircioglu,
  • Cesare Guida,
  • Maxime Dewulf,
  • Christophe Deroose,
  • Valeria Dionisi,
  • John Ramage,
  • Mario Venerito,
  • Mark Burgmans,
  • Carolina de la Pinta,
  • Huw Roach,
  • Serdar Aslan,
  • Stefano Cappio,
  • Christian Stroszczynski,
  • Uli Fehrenbach,
  • Lorenza Rimassa,
  • Lukas Luerken

摘要

Background

Periinterventional imaging of patients with hepatocellular carcinoma (HCC) during local and locoregional therapies plays a crucial role in clinical outcome by guiding treatment allocation, planning, and application. However, there is a considerable variety in clinical routine in terms of timing, modality, and imaging protocols. This study aimed to guide the standardization of the imaging procedures for patients with HCC by conducting a Delphi consensus-finding survey.

Methods

A multidisciplinary, multinational survey was conducted to standardize the imaging of patients with HCC using the Delphi method.

Results

Under the guidance of the European Organisation for Research and Treatment of Cancer (EORTC) Imaging and Gastrointestinal Tract Cancer Groups and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the recommendations for imaging before, during, and after thermal ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy were established.

Conclusion

This consensus protocol provides a foundational guide for imaging in the daily clinical management of HCC patients, as well as for prospective studies assessing local and locoregional therapies.

Key Points

Question There are clear recommendations for the respective therapies/disease stages in HCC, but only to a limited extent for all-around imaging of local therapies.

Findings This study conveyed a Delphi consensus-finding survey amongst European experts from multiple medical fields to standardize the periinterventional imaging of HCC patients.

Clinical relevance These recommendations can guide both daily clinical practice and prospective trials focused on local and locoregional therapies.

Graphical Abstract